Table 1 Patient Characteristics at Study Entry (n = 278)
Characteristic | |
|---|---|
Sex [n (%)] | |
Female | 33 (12) |
Male | 245 (88) |
HIV Transmission Risk Factor [n (%)] | |
MSM1, not IDU2 | 179 (64) |
Heterosexual contact | 52 (19) |
IDU | 23 (8) |
Other/Unknown | 24 (9) |
Race/Ethnicity [n (%)] | |
White | 130 (47) |
Black | 30 (11) |
Hispanic | 87 (31) |
Other/Unknown | 31 (11) |
Age (years) | |
[mean (sd)] | 39.5 (9.2) |
[median (range)] | 39 (19–77) |
ART3 Treatment Experience [n (%)] | |
Naive | 168 (60) |
Experienced | 110 (40) |
Baseline absolute CD4 | |
[mean (sd)] | 201 (163) |
[median (range)] | 173 (0–883) |
Baseline log10 HIV-1 Plasma Viral Load | |
[mean (sd)] | 4.9 (0.7) |
[median (range)] | 5.0 (2.7–6.3) |
Days on new regimen | |
[median (range)] | 286 (30–1221) |
Year of study entry [n (%)] | |
2003 | 51 (18) |
2004 | 103 (37) |
2005 | 81 (29) |
2006 | 43 (16) |
New Regimen Type4 [n(%)] | |
NNRTI & ≥ 2 NRTIs | 63 (23) |
PIb & ≥ 2 NRTIs | 204 (73) |
NNRTI & PIb & ≥ 1 NRTI | 8 (3) |
≥ 2 NRTI | 3 (1) |
# Adherence Scores per patient | |
[median (range)] | 4 (1–27) |